Jonathan Goldman, Director at Avalo Therapeutics, Inc. (AVTX), sold 11,367 shares at $14.35 ($163K) on 2025-11-14, disclosed to the SEC on 2025-11-17.
Open-market sale of $163k AVTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.30 | 3,167 | $45K | 27.8% |
| 2 | $14.35 | 8,200 | $118K | 72.2% |
| Total | $14.34 avg | 11,367 | $163K | 100% |